GlassScriptPhysician profile
George L Shashoua
NPI 1245379551
$9,908.92
in general payments reported to CMS, 2019-2025
42 companies · $786 in 2025
The $786 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,740 · 2020: $1,039 · 2021: $898 · 2022: $1,745 · 2023: $2,031 · 2024: $1,672 · 2025: $786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,381 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,381.29 |
| Education | $106.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,825.78 | 2019-2025 | Saffron |
| Caldera Medical, INC | $1,532.99 | 2022-2025 | Desara |
| Boston Scientific Corporation | $1,389.68 | 2019-2024 | Solyx Sis System |
| Axonics, INC. | $961.07 | 2020-2023 | Axonics, Bulkamid |
| Tela Bio, INC. | $753.11 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $692.57 | 2019-2025 | Botox |
| Allergan, INC. | $495.01 | 2019-2022 | |
| Procept Biorobotics Corporation | $243.58 | 2024 | Aquabeam System |
| Valencia Technologies Corporation | $219.37 | 2025 | Ecoin Device Kit |
| Biotissue Holdings INC. | $200.53 | 2025 | |
| Millicent US INC | $198.87 | 2023-2024 | Intrarosa, Femring |
| Davol INC. | $192.14 | 2022-2024 | Phasix Mesh |
| Intuitive Surgical, INC. | $143.37 | 2022-2023 | Da Vinci Surgical System |
| Srs Medical Systems, INC. | $137.13 | 2023-2024 | Urocuff, Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Astellas Pharma US INC | $122.18 | 2019-2023 | Myrbetriq, Veozah |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Shashoua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.